Skip to main content

Adenosine-induced splenic switch-off on [15O]H2O PET perfusion for the assessment of vascular vasodilatation



Splenic switch-off (SSO) is a marker of adequate adenosine-induced vasodilatation on cardiac magnetic resonance perfusion imaging. We evaluate the feasibility of quantitative assessment of SSO in myocardial positron emission tomography (PET) perfusion imaging using [15O]H2O.


Thirty patients underwent [15O]H2O PET perfusion with adenosine stress. Time-activity curves, as averaged standardized uptake values (SUVavg), were extracted from dynamic PET for spleen and liver. Maximum SUVavg, stress and rest spleen-to-liver ratio (SLR), and the splenic activity concentration ratio (SAR) were computed. Optimal cut-off values for SSO assessment were estimated from receiver operating characteristics (ROC) curve for maximum SUVavg and SLR. Also, differences between coronary artery disease, myocardial ischemia, beta-blockers, and diabetes were assessed. Data are presented as median [interquartile range].


In concordance with the SSO phenomenon, both the spleen maximum SUVavg and SLR were lower in adenosine stress when compared to rest perfusion (8.1 [6.5, 9.2] versus 16.4 [13.4, 19.0], p < 0.001) and (0.81 [0.63, 1.08] versus 1.86 [1.73, 2.06], p < 0.001), respectively. During adenosine stress, the SSO effect was most prominent 40–160 s after radiotracer injection. Cut-off values of 12.6 and 1.57 for maximum SUVavg and SLR, respectively, were found based on ROC analysis. No differences in SAR, SLRRest, or SLRStress were observed in patients with coronary artery disease, myocardial ischemia, or diabetes.


SSO can be quantified from [15O]H2O PET perfusion and used as a marker for adequate adenosine-induced vasodilatation response. In contrary to other PET perfusion tracers, adenosine-induced SSO is time dependent with [15O]H2O.


Positron emission tomography (PET) using [15O]H2O is a gold standard for quantitative noninvasive imaging of myocardial perfusion and its accuracy for myocardial ischemia has been validated in previous multicenter studies [1,2,3,4]. Adequate coronary artery vasodilatation response to adenosine stress is the prerequisite for the successful imaging of myocardial ischemia. Recently, so-called splenic switch-off (SSO) has emerged as a useful imaging marker for adenosine response in cardiac magnetic resonance imaging (CMR) [5, 6]. Adenosine induces splenic vasoconstriction, and the subsequent decrease in spleen blood flow can be seen as a low signal intensity during CMR stress perfusion compared to high signal intensity in the rest perfusion images. Previous CMR studies have shown that SSO is an imaging marker for adenosine-induced myocardial blood flow response [6]. However, the absence of SSO is not necessarily an indicator of failed coronary vasodilatation [6].

The SSO effect has also been previously described in PET perfusion imaging using [13N]ammonia and rubidium-82 tracers with adenosine and dipyridamole for stressors [6,7,8]. Objective imaging marker for successful vasodilator response would be valuable for quantitative PET perfusion as it would allow the differentiation of inadequate vascular adenosine response from balanced ischemia in three-vessel disease or microvascular dysfunction. The technical advantage of PET imaging compared with CMR imaging is that the 3D PET data allow dynamic quantification of spleen, whereas the perfusion slices obtained from CMR are usually not optimized for spleen imaging. In addition, a recent case series reported SSO phenomenon in [15O]H2O perfusion after adenosine stress [9]. However, the authors only presented the extracardiac finding lacking a dedicated quantitative assessment of the SSO phenomenon.

In our study, we quantitatively assess the clinical utility of SSO as a marker for adequate vascular vasodilator response to adenosine stress on [15O]H2O PET perfusion imaging. We describe the feasibility and cut-off values of SSO in [15O]H2O perfusion for further use in clinical practice and research.


Study design

The study population consisted of a retrospective cohort of 30 consecutive patients who underwent [15O]H2O PET perfusion at rest and adenosine stress at Helsinki University Hospital for evaluation of myocardial ischemia. A history of coronary artery disease, diabetes, hypertension, smoking, and hypercholesterolemia was collected from hospital records. The exclusion criteria were the inability to complete the standard PET perfusion protocol. Written informed consent was obtained from all participants. The study was performed according to the Declaration of Helsinki, and the study protocol was approved by the local ethics committee (HUS/1226/2019) and the Helsinki University Hospital’s institutional research board.

PET image acquisition

All patients were imaged using a standard clinical [15O]H2O myocardial PET perfusion protocol. The patients were instructed to abstain from caffeine for 24 h prior to the PET study. Sequential acquisition of helical low-dose computed tomography (CT) for attenuation correction and PET perfusion scans were performed using a digital 4-ring detector time-of-flight PET/CT system (Discovery MI PET/CT, GE Healthcare, Waukesha, WI, USA). Rest perfusion was performed first, and after a 10-min pause for radiotracer clearance stress perfusion was obtained. The target dose was 600 MBq per PET scan (range 416–715 MBq). A standard 6 min adenosine stress was used during the stress perfusion with radiotracer injection 2 min after the initiation of adenosine infusion at 140 µg/kg/min. The scan parameters were identical in both scans. List mode PET data were acquired and reconstructed as dynamic and divided into frames as 14 × 5 s; 3 × 10 s; 3 × 20 s; 4 × 30 s (total time: 4 min 40 s). PET images were reconstructed with the iterative Q.Clear algorithm (GE Healthcare, Waukesha, WI, USA) with 256 × 256 matrix size. The pixel size and slice thickness were set to 2.73 mm and 2.79 mm, respectively.

PET analysis of SSO and myocardial blood flow

The assessment of SSO was done retrospectively for research purposes only from the time-activity curves (TACs) extracted from the dynamic PET data using Syngo.via (Siemens Healthineers Forchheim, Germany) software’s MM Oncology package. Spherical volumes of interest (VOI) were manually drawn in the liver (mean: 116 cm3 [50, 292] cm3) and spleen (mean: 11 cm3, [6, 25] cm3), and then activity concentration (kBq/ml) TAC as average values from the VOI region were exported in a tabular format (.csv).

Further processing of the ta TAC values was performed in Python v. 3.8 using custom codes. The average activity concentration values from PET data were transformed into average standardized uptake values (SUVavg) using the administered tracer dose and patient weight. The following parameters were extracted from the SUVavg TAC: Time to peak SUVavg in rest spleen, Maximum SUVavg value from the spleen TAC, Spleen-to-liver SUVavg ratio (SLR) both during stress and rest (SLR = Maximum splenic SUVavg/Maximum liver SUVavg) and the splenic SUVavg ratio (SAR = Maximum splenic activityStress/Maximum splenic activityRest).

No independent ground truth method (such as gadolinium-enhanced CMR in PET-MR) for the SSO assessment was available. However, in our patient population, the spleen maximum SUVavg and SLR values systematically decreased during adenosine stress showing SSO. Only two patients out of 30 had an opposing slight increase in the spleen maximum SUVavg and SLR values in stress compared to rest.

Quantitative global left ventricular myocardial perfusion values were obtained for rest and stress PET scans using Carimas™ (Cardiac Image Analysis System) software package [10]. PET images were read by nuclear medicine physician with more than 10 years of experience with PET perfusion imaging (VU) who established the diagnosis of myocardial ischemia based on the quantitative perfusion data. Previously validated cut-off values for stress myocardial blood flow (MBF) of 2.3 ml/min/g and for myocardial flow reserve (MFR) of 2.5 were used to define the presence of myocardial ischemia [2]. For one patient, the myocardial rest perfusion analysis was omitted due to poor quality of data.

Statistical analysis

Continuous variables are reported as mean ± standard deviation (SD) and median [interquartile range] for normally distributed and skewed data. Categorical variables are reported as numbers and percentages. Due to sample size (N = 30), a nonparametric Wilcoxon signed-rank test was chosen for comparison of stress and rest spleen SUVs at different time points and SLRs. TACs were used to evaluate the optimal time-points for quantification of the SSO phenomenon. Spleen rest TAC was compared with spleen stress TAC to evaluate the adenosine-induced SSO phenomenon during stress imaging. In addition, boxplot analyses were performed to investigate possible differences in SSO reaction in patients with diabetes, previously known coronary artery disease, or myocardial ischemia at PET perfusion. Boxplots displayed a sample median as horizontal line, a first and third quartiles as boxplot edges, whiskers, which were set to first quantile—1.5 interquartile range and third quantile + 1.5 interquartile range, and outliers, i.e., values outside whiskers as circles. The statistical differences between these groups were assessed using Welch’s t-test. Correlations were analyzed using Pearson’s correlation.

A receiver characteristics operating curve (ROC) analysis was used to evaluate the optimal cut-off value to differentiate rest perfusion images from the stress perfusion. Area under ROC curve (ROC AUC), sensitivity, and specificity were calculated, and the optimal cut-off point was determined from Youden's index maximum.

The limit for statistically significant differences was set to p < 0.001. All statistical analyses were conducted in Python using SciPy (v. 1.10.0) and Pandas (v. 1.5.2), scikit-learn (v.1.2.1) libraries [11].


The study population consisted of 30 patients who underwent [15O]H2O PET perfusion imaging. Patient characteristics are shown in Table 1.

Table 1 Patient characteristics

Quantification of splenic switch-off from PET

Differences were observed between spleen rest and stress axial PET reconstructions and TACs (Fig. 1). Dynamic assessment showed that between 40 and 160 s the SSO caused by the adenosine-induced stress statistically significantly decreased SUV values (Fig. 1c.). The median time-to-maximum SUVavg in spleen rest was found to be 65 [55,75] seconds. Both maximum SUVavg extracted from TAC and SLRs were lower in stress compared with rest (maximum SUVavg: 8.1 [6.5, 9.2] vs. 16.4 [13.4, 19.0]; SLR: 0.81 [0.63,1.08] vs. 1.86 [1.73, 2.06]) (Fig. 2b, c). The median SAR was 0.48 [0.42, 0.59] (Fig. 2).

Fig. 1
figure 1

Static 5 s frame reconstruction of rest (a) and stress (b) perfusion PET scans after 1 min of [15O]H2O injection (windowing: [0, 140] kBq/ml in both images). The spleen (white arrow) [15O]H2O perfusion is reduced due to the splenic switch-off phenomenon consistent with a good vascular adenosine stress response. Mean time-activity curves (± standard deviation, dashed line) for rest and adenosine induced stress for spleen (c) and liver (d). Splenic switch-off effect during stress is shown as decreased [15O]H2O activity especially at the timepoints starting at 40 s to 160 s (statistically significant difference p ≤ 0.001 highlighted in green)

Fig. 2
figure 2

Boxplot of splenic activity ratio (SAR) values. Median was 0.48 (orange) and interquartile range (box edges) was [0.42, 0.59]

When classifying stress and rest based on maximum SUVavg and SLRs, the ROC analysis revealed that the most optimal cut-off values were 12.6 (0.93 specificity and 0.76 sensitivity) and 1.57 (0.93 specificity and 0.9 sensitivity) for maximum SUVavg and SLR, respectively (Fig. 3a, b).

Fig. 3
figure 3

Receiver operating characteristic (ROC) curves for maximum average standardized uptake values (SUVavg) (a) and Spleen-to-liver ratio (SLR) (b) and their area under area under ROC (ROC AUC) values. Boxplots presenting maximum SUVavg values extracted from spleen time-activity curves (c) and SLR (d). In both cases, there were statistically significant difference between rest and stress groups

Association between myocardial [15O]H2O perfusion and splenic switch-off

A strong negative correlation (r = − 0.71, p < 0.001) was found between SLR and global myocardial blood flow (MBF) (Fig. 4a). However, no correlation was found between SAR and myocardial flow reserve (MFR) (Fig. 4b). There were 11 (37%) patients with myocardial ischemia of which three patients had global balanced reduction in myocardial perfusion. These three patients received a diagnosis of diffuse atherosclerosis and/or microvascular disease and two of them showed SSO response as a lower maximum SUVavg and SLR in the spleen during stress.

Fig. 4
figure 4

Scatterplots spleen-to-liver ratio (SLR) versus global myocardial blood flow (MBF) (a) and spleen activity ratio (SAR) versus myocardial flow reserve (MFR) (b). Patients with myocardial ischemia is denoted with × marker in the scatterplots

Risk factors and splenic switch-off

Risk factors should not affect the SSO effect and therefore, additional box plot analysis was conducted (Fig. 5). We found that no statistically significant differences were found between diabetes, beta-blocker use, CAD, gender, and myocardial ischemia in PET patients for SAR and SLR (Fig. 5).

Fig. 5
figure 5

Boxplots showing spleen activity ratios (SAR), rest and stress spleen-to-liver ratios (SLR) for diabetes mellitus (DM), beta-blockers, coronary artery disease (CAD), myocardial ischemia, and gender groups. No statistically significant differences were found between groups


In this study, we have demonstrated and quantified the adenosine-induced splenic switch-off effect in the [15O]H2O in stress myocardial perfusion. We show that the [15O]H2O tracer can be utilized in the SSO assessment, which implies adequate coronary adenosine-induced myocardial blood flow response similar to previous stress CMR and other PET radiotracers studies [5,6,7,8]. The visual and quantitative assessment of the SSO phenomenon is most feasible at the perfusion phase of 40–160 s (Fig. 1c). Also, our results indicate that the simpler maximum SUVavg could also be used in SSO assessment instead of the previously introduced SLR. We propose thresholds of 12.6 and 1.57 for stress spleen maximum SUVavg and SLRStress, respectively, indicating a positive SSO effect.

Previous studies have investigated the SSO effect on adenosine stress [13N]ammonia PET and dipyridamole stress Rubidium-82 PET perfusion [6,7,8]. The SAR values in our study were similar (0.48 [0.42, 0.59]) to the patients with positive SSO with adenosine stress [13N]ammonia PET (0.4 [0.32, 0.45]) [7]. For [13N]ammonia and rubidium-82 SLRStress values ≤ 0.92 and 0.71, respectively, were proposed as normal positive splenic response. We observed a quite similar SLRStress values (≤ 1.57) to the previous [13N]ammonia threshold. It should be noted that the [15O]H2O does not accumulate in the liver similar to[13N]ammonia and has relatively rapid perfusion as shown in Fig. 1d. Therefore, even though the SLRStress values were similar in [15O]H2O and [13N]ammonia, the dynamic kinetic process between the tracers is different which might affect the spleen-to-liver ratio comparisons.

In previous dynamic perfusion PET studies, the kinetics of radiopharmaceuticals have been reported barely. For [13N]ammonia, high SUV values were reported for the spleen over a whole dynamic rest perfusion PET study (up to 7 min) compared to a stress study [7], indicating positive SSO. We found that the kinetics of [15O]H2O is more rapid due to tracer wash out (Fig. 1), and timing for SSO assessment is crucial. Based on our spleen SUVavg assessment, we propose that possible SSO is measured optimally from PET images 60 s after [15O]H2O injection as this yielded highest statistically significant differences between stress and rest (Fig. 1c). Our study analyzed SSO from a single PET frame (5 to 10 s long) and found that SSO assessment from the dynamic data was feasible. Secondary static reconstruction from the list mode data for the SSO assessment 60 s after injection could be used for visual and quantitative SUV assessment of SSO in clinical practice, as demonstrated in Fig. 1a, b with single 5 s frame.

Our study is unique to previous studies as we describe and validate a simple splenic SUV threshold to quantitatively evaluate the SSO phenomenon from stress-only perfusion images. Previous studies have demonstrated that absolute stress MBF is enough for an accurate evaluation of myocardial ischemia, and rest perfusion can usually be omitted in [15O]H2O PET perfusion imaging [2, 12]. Spleen SUV quantitation, we describe is a simple and easily standardizable measure for clinical practice and could even be used by technicians after the perfusion imaging as a quality control step to evaluate whether the adenosine stress was successful. Due to the short half-life of [15O]H2O, stress perfusion can be easily repeated at the same imaging session as necessary with a low additional radiation dose.

The main limitation of this study was the lack of reference standard for PET measured SSO phenomenon. However, we included 30 clinical PET perfusion patients who were screened for caffeine consumption before imaging. Furthermore, comparison with CMR might be problematic due to the superior flow properties of [15O]H2O compared to gadolinium contrast. Nevertheless, combined PET and magnetic resonance (PET/MR) hybrid imaging would be good modality to cross-validate SSO phenomenon and to evaluate our quantitative PET measures. We did not perform laboratory tests for blood caffeine levels in our study. Interestingly, one previous study showed that SSO imaging failed to detect the effect of caffeine consumption on splenic stress response, which should be explored further in another study using quantitative PET [13]. We observed good vasodilation in the coronary arteries in most cases with quantitative [15O]H2O PET perfusion. Three patients had balanced ischemia and received diagnosis of microvascular and/or diffuse atherosclerosis, and one of them had poor SSO, which confounded the assessment of coronary adenosine response. A larger patient cohort should be used to validate and assess the diagnostic implications of SSO thresholds derived from our study and assess its impact on patient management. The sample size of our study was small, and we cannot study small differences in quantitative SSO in coronary risk factors such as diabetes or peripheral atherosclerosis possibly affecting the portal blood flow. We were unable to study the associations between hemodynamic parameters, symptom severity, and SSO phenomenon during adenosine stress due to our retrospective study setting, and it should be explored in a further prospective study.

Several factors affect the SUV quantification accuracy. The weight was only asked and was not measured before imaging causing small error in the SUV quantification. The imaging was performed using only a single scanner, and factors such as reconstruction algorithm and parameters, acquisition protocol, and scanner-related physical correction models affect to the SUV quantification. Further prospective validation study should be done prior to clinical adaptation of our quantitative SSO cut-off values to study their accuracy in larger population.


Splenic switch-off can be observed and quantitatively measured in [15O]H2O PET perfusion during adenosine stress. [15O]H2O tracer kinetics were rapid in the spleen, and the statistically significant differences found between rest and stress time-activity curves revealed that the splenic switch-off was most apparent at 40–160 s after tracer injection. In this study, spleen maximum SUVavg value < 12.6 and spleen-to-liver ratio < 1.57 were found as a simple and clinically useful thresholds to evaluate the adequate vascular response in adenosine stress.

Availability of data and materials

The data that support the findings of this study are not openly available due to reasons of sensitivity and are available from the corresponding author upon reasonable request.



Cardiac magnetic resonance imaging


Computed tomography


Myocardial blood flow


Myocardial flow reserve


Positron emission tomography


Receiver operating characteristics


Area under receiver operating characteristics curve


Splenic activity concentration ratio


Standard deviation


Spleen-to-liver ratio


Splenic switch-off

SUVavg :

Average standardized uptake values


Standardized uptake value


Time-activity curves


  1. Danad I, Raijmakers PG, Driessen RS, Leipsic J, Raju R, Naoum C, et al. Comparison of coronary CT angiography, SPECT, PET, and hybrid imaging for diagnosis of ischemic heart disease determined by fractional flow reserve. JAMA Cardiol. 2017;2:1100–7.

    Article  PubMed  PubMed Central  Google Scholar 

  2. Danad I, Uusitalo V, Kero T, Saraste A, Raijmakers PG, Lammertsma AA, et al. Quantitative assessment of myocardial perfusion in the detection of significant coronary artery disease: cutoff values and diagnostic accuracy of quantitative [(15)O]H2O PET imaging. J Am Coll Cardiol. 2014;64:1464–75.

    Article  PubMed  Google Scholar 

  3. Maaniitty T, Knuuti J, Saraste A. 15O-water PET MPI: current status and future perspectives. Semin Nucl Med. 2020;50:238–47.

    Article  PubMed  Google Scholar 

  4. Saraste A, Kajander S, Han C, Nesterov SV, Knuuti J. PET: is myocardial flow quantification a clinical reality? J Nucl Cardiol. 2012;19:1044–59.

    Article  PubMed  Google Scholar 

  5. Manisty C, Ripley DP, Herrey AS, Captur G, Wong TC, Petersen SE, et al. Splenic switch-off: a tool to assess stress adequacy in adenosine perfusion cardiac MR imaging. Radiology. 2015;276:732–40.

    Article  PubMed  Google Scholar 

  6. Patriki D, von Felten E, Bakula A, Giannopoulos AA, Kamani CH, Schwyzer M, et al. Splenic switch-off as a predictor for coronary adenosine response: validation against 13N-ammonia during co-injection myocardial perfusion imaging on a hybrid PET/CMR scanner. J Cardiovasc Magn Reson. 2021;23:3.

    Article  PubMed  PubMed Central  Google Scholar 

  7. Bakula A, Patriki D, von Felten E, Benetos G, Sustar A, Benz DC, et al. Splenic switch-off as a novel marker for adenosine response in nitrogen-13 ammonia PET myocardial perfusion imaging: cross-validation against CMR using a hybrid PET/MR device. J Nucl Cardiol. 2022;29:1205–14.

    Article  PubMed  Google Scholar 

  8. Bami K, Tewari S, Guirguis F, Garrard L, Guo A, Hossain A, et al. Prognostic utility of splenic response ratio in dipyridamole PET myocardial perfusion imaging. J Nucl Cardiol. 2019;26:1888–97.

    Article  PubMed  Google Scholar 

  9. Jochumsen MR, Overgaard DL, Vendelbo MH, Madsen MA, Tolbod LP, Gormsen LC, et al. Extracardiac findings with increased perfusion during clinical O-15-H(2)O PET/CT myocardial perfusion imaging: a case series. J Nucl Cardiol. 2023;1:11.

    Article  Google Scholar 

  10. Nesterov SV, Han C, Maki M, Kajander S, Naum AG, Helenius H, et al. Myocardial perfusion quantitation with 15O-labelled water PET: high reproducibility of the new cardiac analysis software (Carimas). Eur J Nucl Med Mol Imaging. 2009;36:1594–602.

    Article  PubMed  Google Scholar 

  11. Virtanen P, Gommers R, Oliphant TE, Haberland M, Reddy T, Cournapeau D, et al. SciPy 1.0: fundamental algorithms for scientific computing in Python. Nat Methods. 2020;17:261–72.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  12. Kajander S, Joutsiniemi E, Saraste M, Pietila M, Ukkonen H, Saraste A, et al. Cardiac positron emission tomography/computed tomography imaging accurately detects anatomically and functionally significant coronary artery disease. Circulation. 2010;122:603–13.

    Article  CAS  PubMed  Google Scholar 

  13. Seitz A, Kaesemann P, Chatzitofi M, Tauscher G, Bekeredjian R, et al. Impact of caffeine on myocardial perfusion reserve assessed by semiquantitative adenosine stress perfusion cardiovascular magnetic resonance. J Cardiovasc Magn Reason. 2019;21:33.

    Article  Google Scholar 

Download references


Not applicable.


Open Access funding provided by University of Helsinki (including Helsinki University Central Hospital). The authors declare that no funds, grants, or other support were received during the preparation of this manuscript. Open access funded by Helsinki University Library.

Author information

Authors and Affiliations



All authors contributed to the study’s conception and design. Material preparation, data collection, and analysis were performed by SI, EH, and VU. The first draft of the manuscript was written by SI and all authors commented on previous versions of the manuscript. All authors read and approved the final manuscript.

Corresponding author

Correspondence to Satu Irene Inkinen.

Ethics declarations

Ethics approval and consent to participate

This study was performed in line with the principles of the Declaration of Helsinki. Approval was granted by the Ethics Committee of Helsinki University Hospital (HUS/1226/2019). Informed consent was obtained from all individual participants included in the study.

Consent for publication

The authors affirm that human research participants provided informed consent for the publication of the images in Fig. 1.

Competing interests

Valtteri Uusitalo has had lecture fees and advisory board activity with Pfizer and GE Healthcare. The authors have no other relevant financial or non-financial interests to disclose.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit

Reprints and Permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Inkinen, S.I., Hippeläinen, E. & Uusitalo, V. Adenosine-induced splenic switch-off on [15O]H2O PET perfusion for the assessment of vascular vasodilatation. EJNMMI Res 13, 96 (2023).

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: